Obesity and diabetes genes are associated with being born small for gestational age: Results from the Auckland Birthweight Collaborative study

BMC Medical Genetics

Volumn 11, Issue 1, 2010, Pages

  Morgan, Angharad R ^a,b   Thompson, John M D ^a   Murphy, Rinki ^a   Black, Peter N ^a   Lam, Wen Jiun ^a,b   Ferguson, Lynnette R ^a,b   Mitchell, Ed A ^a  

^a THE UNIVERSITY OF AUCKLAND   (New Zealand)

^b Nutrigenomics New Zealand   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; PFKP PROTEIN; PTER PROTEIN; SEC16B PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CHILD; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; NEW ZEALAND; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; SMALL FOR DATE INFANT; BIRTH WEIGHT; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; FEMALE; GESTATIONAL AGE; NEWBORN; PREGNANCY; RISK FACTOR;

BIRTH WEIGHT; CARDIOVASCULAR DISEASES; CHILD; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; OBESITY; PREGNANCY; RISK FACTORS;

EID: 77955542332     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-11-125     Document Type: Article

References (78)

1. Alkalay AL, Graham JM, Pomerance JJ. Evaluation of neonates born with intrauterine growth retardation: review and practice guidelines. J Perinatol 1998, 18:142-151.
2. Lee PA, Chernausek SD, Hokken-Koelega AC, Czernichow P, . International Small for Gestational Age Advisory Board International Small for Gestational Age Advisory Board: International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24 - October 1, 2001. Pediatrics 2001, 111:1253-1261. International Small for Gestational Age Advisory Board.
3. Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, Osmond C, Winter PD. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 1991, 303:1019-1022. 10.1136/bmj.303.6809.1019, 1671766, 1954451.
4. Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and cardiovascular disease in adult life. Lancet 1993, 341:938-941. 10.1016/0140-6736(93)91224-A, 8096277.
5. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993, 36:62-67. 10.1007/BF00399095, 8436255.
6. Parsons TJ, Power C, Manor O. Fetal and early life growth and body mass index from birth to early adulthood in 1958 British cohort: longitudinal study. BMJ 2001, 323(7325):1331. 10.1136/bmj.323.7325.1331, 60670, 11739217.
7. Singhal A, Wells J, Cole TJ, Fewtrell M, Lucas A. Programming of lean body mass: a link between birth weight, obesity, and cardiovascular disease?. Am J Clin Nutr 2003, 77(3):726-30.
8. Hattersley AT, Tooke JE. The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease. Lancet 1999, 353:1789-1792. 10.1016/S0140-6736(98)07546-1, 10348008.
9. Barker DJ. The fetal and infant origins of adult disease. BMJ 1990, 301:1111. 10.1136/bmj.301.6761.1111, 1664286, 2252919.
10. Barker DJP. Mothers, babies, and disease in later life 1994, London, United Kingdom: BMJ Books.
11. Barker DJP. Maternal nutrition, fetal nutrition and diseases in later life. Nutrition 1997, 13:807. 10.1016/S0899-9007(97)00193-7, 9290095.
12. Singhal A, Lucas A. Early origins of cardiovascular disease: is there a unifying hypothesis?. Lancet 2004, 363:1642-1645. 10.1016/S0140-6736(04)16210-7, 15145640.
13. Kramer MS. Determinants of low birth weight: methodological assessment and meta analysis. Bull WHO 1987, 65:663-737. 2491072, 3322602.
14. Thompson JM, Clark PM, Robinson E, Becroft DM, Pattison NS, Glavish N, Pryor JE, Wild CJ, Rees K, Mitchell EA. Risk factors for small-for-gestational-age babies: The Auckland birthweight collaborative study. J Paediatr Child Health 2001, 37:369-375. 10.1046/j.1440-1754.2001.00684.x, 11532057.
15. Mitchell EA, Robinson E, Clark PM, Becroft DM, Glavish N, Pattison NS, Pryor JE, Thompson JM, Wild CJ. Maternal nutritional risk factors for small for gestational age babies in a developed country: a case-control study. Arch Dis Child Fetal Neonatal Ed 2004, 89(5):F431-F435. 10.1136/adc.2003.036970, 1721755, 15321964.
16. Wang X, Zuckerman B, Coffman GA, Corwin MJ. Familial aggregation of low birth weight among whites and blacks in the United States. N Engl J Med 1995, 333:1744-1749. 10.1056/NEJM199512283332606, 7491139.
17. Magnus P, Bakketeig LS, Hoffman H. Birth weight of relatives by maternal tendency to repeat small-for-gestational-age (SGA) births in successive pregnancies. Acta Obstet Gynecol Scand Suppl 1997, 165:35-38.
18. Infante-Rivard C. Studying genetic predisposition among small-for-gestational-age newborns. Semin Perinatol 2007, 31(4):213-218. 10.1053/j.semperi.2007.05.001, 17825675.
19. Howley EA, Walker M, Rodger MA. A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction. Am J Obstet Gynecol 2005, 192:694-708. 10.1016/j.ajog.2004.09.011, 15746660.
20. Infante-Rivard C, Rivard GE, Guiguet M, Gauthier R. Thrombophilic polymorphisms and intrauterine growth restriction. Epidemiology 2005, 16:281-287. 10.1097/01.ede.0000158199.64871.b9, 15824541.
21. Wang X, Zuckerman B, Pearson C, Kaufman G, Chen C, Wang G, Niu T, Wise PH, Bauchner H, Xu X. Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA 2002, 287:195-202. 10.1001/jama.287.2.195, 11779261.
22. Infante-Rivard C, Weinberg CR, Guiguet M. Xenobiotic-metabolizing genes and small-for-gestational-age births: interaction with maternal smoking. Epidemiology 2006, 17:38-46. 10.1097/01.ede.0000187669.34003.b1, 16357593.
23. Infante-Rivard C, Lévy E, Rivard GE, Guiguet M, Feoli-Fonseca JC. Small babies receive the cardiovascular protective apolipoprotein 2 allele less frequently than expected. J Med Genet 2003, 40:626-629. 10.1136/jmg.40.8.626, 1735546, 12920078.
24. Akisu M, Balim Z, Cetin H, Kosova B, Yalaz M, Topcuoglu N, Kultursay N. The role of angiotensin-converting enzyme and apolipoprotein-E gene polymorphisms on lipid compositions in newborn infants with intrauterine growth restriction. Early Hum Dev 2004, 78:95-103. 10.1016/j.earlhumdev.2004.03.006, 15223114.
25. Chen D, Hu Y, Chen C, Yang F, Fang Z, Wang L, Li J. Polymorphisms of the paraoxonase gene and risk of preterm delivery. Epidemiology 2004, 15:466-470. 10.1097/01.ede.0000129509.59912.b2, 15232408.
26. Vaessen N, Janssen JA, Heutink P, Hofman A, Lamberts SW, Oostra BA, Pols HA, van Duijn CM. Association between genetic variation in the gene for insulin-like growth factor-I and low birthweight. Lancet 2002, 359:1036-1037. 10.1016/S0140-6736(02)08067-4, 11937187.
27. Thompson JM, Mitchell EA, Borman B. Sex specific birthweight percentiles by gestational age for New Zealand. N Z Med J 1994, 107:1-3.
28. Jurinke C, van den Boom D, Cantor CR, Köster H. The use of massARRAY technology for high throughput genotyping. Adv Biochem Eng Biotechnol 2002, 77:57-74.
29. Storm N, Darnhofer-Patel B, van den Boom D, Rodi CP. MALDI-TOF mass spectrometry-based SNP genotyping. Methods Molecular Biology 2003, 212:241-262.
30. Ihaka R, Gentleman R. R: A language for data analysis and graphics. Journal of Computational and Graphical Statistics 1996, 5:299-314.
31. Weedon MN, Gloyn AL, Frayling TM, Hattersley AT, Davey Smith G, Ben-Shlomo Y. Quantitative traits associated with the Type 2 diabetes susceptibility allele in Kir6.2. Diabetologia 2003, 46(7):1021-1023. 10.1007/s00125-003-1135-3, 12819904.
32. Bennett AJ, Sovio U, Ruokonen A, Martikainen H, Pouta A, Hartikainen AL, Franks S, Elliott P, Järvelin MR, McCarthy MI. No evidence that established type 2 diabetes susceptibility variants in the PPARG and KCNJ11 genes have pleiotropic effects on early growth. Diabetologia 2008, 51(1):82-85. 10.1007/s00125-007-0863-1, 17994213.
33. Adair LS, Prentice AM. A critical evaluation of the fetal origins hypothesis and its implications for developing countries. J Nutr 2004, 134:191-193.
34. Shugart YY, Chen L, Day IN, Lewis SJ, Timpson NJ, Yuan W, Abdollahi MR, Ring SM, Ebrahim S, Golding J, Lawlor DA, Davey-Smith G. Two British women studies replicated the association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) and BMI. Eur J Hum Genet 2009, 17:1050-1055. 10.1038/ejhg.2008.272, 19209189.
35. Freathy RM, Bennett AJ, Ring SM, Shields B, Groves CJ, Timpson NJ, Weedon MN, Zeggini E, Lindgren CM, Lango H, Perry JR, Pouta A, Ruokonen A, Hyppönen E, Power C, Elliott P, Strachan DP, Järvelin MR, Smith GD, McCarthy MI, Frayling TM, Hattersley AT. Type 2 Diabetes Risk Alleles are Associated with Reduced Size at Birth. Diabetes 2009, 58(6):1428-1433. 10.2337/db08-1739, 2682672,2682672, 19228808.
36. Zhao J, Li M, Bradfield JP, Wang K, Zhang H, Sleiman P, Kim CE, Annaiah K, Glaberson W, Glessner JT, Otieno FG, Thomas KA, Garris M, Hou C, Frackelton EC, Chiavacci RM, Berkowitz RI, Hakonarson H, Grant SF. Examination of type 2 diabetes loci implicates CDKAL1 as a birth weight gene. Diabetes 2009, 58(10):2414-2418. 10.2337/db09-0506, 19592620.
37. Pulizzi N, Lyssenko V, Jonsson A, Osmond C, Laakso M, Kajantie E, Barker DJ, Groop LC, Eriksson JG. Interaction between prenatal growth and high-risk genotypes in the development of type 2 diabetes. Diabetologia 2009, 52(5):825-829. 10.1007/s00125-009-1291-1, 19225753.
38. Cauchi S, Meyre D, Choquet H, Deghmoun S, Durand E, Gaget S, Lecoeur C, Froguel P, Levy-Marchal C. TCF7L2 rs7903146 variant does not associate with smallness for gestational age in the French population. BMC Med Genet 2007, 8:37. 10.1186/1471-2350-8-37, 1920504, 17593304.
39. Mook-Kanamori DO, de Kort SW, van Duijn CM, Uitterlinden AG, Hofman A, Moll HA, Steegers EA, Hokken-Koelega AC, Jaddoe VW. Type 2 diabetes gene TCF7L2 polymorphism is not associated with fetal and postnatal growth in two birth cohort studies. BMC Med Genet 2009, 10:67. 10.1186/1471-2350-10-67, 2722586, 19615048.
40. Freathy RM, Weedon MN, Bennett A, Hypponen E, Relton CL, Knight B, Shields B, Parnell KS, Groves CJ, Ring SM, Pembrey ME, Ben-Shlomo Y, Strachan DP, Power C, Jarvelin MR, McCarthy MI, Davey Smith G, Hattersley AT, Frayling TM. Type 2 diabetes TCF7L2 risk genotypes alter birth weight: a study of 24,053 individuals. Am J Hum Genet 2007, 80:1150-1161. 10.1086/518517, 1867102, 17503332.
41. Dupont WD, Plummer WD. Power and Sample Size Calculations for Studies Involving Linear Regression. Controlled Clinical Trials 1998, 19:589-601. 10.1016/S0197-2456(98)00037-3, 9875838.
42. Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R, Ellard S. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nature Genetics 1998, 19:268-270. 10.1038/953, 9662401.
43. Freathy RM, Mook-Kanamori DO, Sovio U, et al. Variants in ADCY5 and near CCNL1 are associated with fetal growth and birth weight. Nature Genetics 2010, 42:430-435. 10.1038/ng.567, 20372150.
44. Dupuis J, Langenberg C, Prokopenko I, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010, 42:105-116. 10.1038/ng.520, 20081858.
45. Zeggini E, Scott LJ, Saxena R, et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nature Genetics 2008, 40:638-645. 10.1038/ng.120, 2672416, 18372903.
46. Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3000 shared controls. Nature 2007, 447:661-678. 10.1038/nature05911, 2719288, 17554300, Wellcome Trust Case Control Consortium.
47. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H, Timpson NJ, Perry JR, Rayner NW, Freathy RM, Barrett JC, Shields B, Morris AP, Ellard S, Groves CJ, Harries LW, Marchini JL, Owen KR, Knight B, Cardon LR, Walker M, Hitman GA, Morris AD, Doney AS, , McCarthy MI, Hattersley AT. Wellcome Trust Case Control Consortium (WTCCC) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007, 316:1336-1341. 10.1126/science.1142364, 17463249, Wellcome Trust Case Control Consortium (WTCCC).
48. Scott LJ, Mohlke KL, Bonnycastle LL, et al. A genome wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007, 316:1341-1345. 10.1126/science.1142382, 17463248.
49. Deeb SS, Fajas L, Nemoto M, Pihlajamäki J, Mykkänen L, Kuusisto J, Laakso M, Fujimoto W, Auwerx J. A Pro12Ala substitution in PPARy2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nature Genetics 1998, 20:284-287. 10.1038/3099, 9806549.
50. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer C, Tuomi T, Gaudet D, Hudson TJ, Daly M, Groop L, Lander ES. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nature Genetics 2000, 26:76-80. 10.1038/79839, 10973253.
51. Sandhu MS, Weedon MN, Fawcett KA, Wasson J, Debenham SL, Daly A, Lango H, Frayling TM, Neumann RJ, Sherva R, Blech I, Pharoah PD, Palmer CN, Kimber C, Tavendale R, Morris AD, McCarthy MI, Walker M, Hitman G, Glaser B, Permutt MA, Hattersley AT, Wareham NJ, Barroso I. Common variants in WFS1 confer risk of type 2 diabetes. Nature Genetics 2007, 39:951-953. 10.1038/ng2067, 2672152, 17603484.
52. Florez JC, Jablonski KA, McAteer J, Sandhu MS, Wareham NJ, Barroso I, Franks PW, Altshuler D, Knowler WC, . Diabetes Prevention Program Research Group Testing of diabetes-associated WFS1 polymorphisms in the diabetes prevention program. Diabetologica 2008, 51:451-457. Diabetes Prevention Program Research Group.
53. Franks PW, Rolandsson O, Debenham SL, Fawcett KA, Payne F, Dina C, Froguel P, Mohlke KL, Willer C, Olsson T, Wareham NJ, Hallmans G, Barroso I, Sandhu MS. Replication of the association between variants in WFS1 and risk of type 2 diabetes in European populations. Diabetologica 2008, 51:458-463.
54. Steinthorsdottir V, Thorleifsson G, Reynisdottir I, et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nature Genetics 2007, 39:770-775. 10.1038/ng2043, 17460697.
55. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, Helgason A, Stefansson H, Emilsson V, Helgadottir A, Styrkarsdottir U, Magnusson KP, Walters GB, Palsdottir E, Jonsdottir T, Gudmundsdottir T, Gylfason A, Saemundsdottir J, Wilensky RL, Reilly MP, Rader DJ, Bagger Y, Christiansen C, Gudnason V, Sigurdsson G, Thorsteinsdottir U, Gulcher JR, Kong A, Stefansson K. Variant of transcription factor 7 like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nature Genetics 2006, 38:320-323. 10.1038/ng1732, 16415884.
56. Helgason A, Pálsson S, Thorleifsson G, et al. Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nature Genetics 2007, 39:218-225. 10.1038/ng1960, 17206141.
57. Hani EH, Boutin P, Durand E, Inoue H, Permutt MA, Velho G, Froguel P. Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR): a meta-analysis suggests a role in the polygenic basis of type II diabetes mellitus in Caucasians. Diabetologia 1998, 41:1511-1515. 10.1007/s001250051098, 9867219.
58. Gloyn AL, Weedon MN, Owen KR, Turner MJ, Knight BA, Hitman G, Walker M, Levy JC, Sampson M, Halford S, McCarthy MI, Hattersley AT, Frayling TM. Large scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 2003, 52:568-572. 10.2337/diabetes.52.2.568, 12540637.
59. Nielsen EM, Hansen L, Carstensen B, Echwald SM, Drivsholm T, Glümer C, Thorsteinsson B, Borch-Johnsen K, Hansen T, Pedersen O. The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes. Diabetes 2003, 52:573-577. 10.2337/diabetes.52.2.573, 12540638.
60. Prokopenko I, Langenberg C, Florez JC, et al. Variants in MTNR1B influence fasting glucose levels. Nature Genetics 2009, 41(1):77-81. 10.1038/ng.290, 2682768, 19060907.
61. Lyssenko V, Nagorny CL, Erdos MR, et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nature Genetics 2009, 41(1):82-88. 10.1038/ng.288, 19060908.
62. Bouatia-Naji N, Bonnefond A, Cavalcanti-Proença C, et al. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nature Genetics 2009, 41(1):89-94. 10.1038/ng.277, 19060909.
63. Gudmundsson J, Sulem P, Steinthorsdottir V, et al. Two variants on chromosome 17 confer prostate cancer risk, and the one in TC2 protects against type 2 diabetes. Nature Genetics 2007, 39:977-983. 10.1038/ng2062, 17603485.
64. Winckler W, Weedon MN, Graham RR, McCarroll SA, Purcell S, Almgren P, Tuomi T, Gaudet D, Boström KB, Walker M, Hitman G, Hattersley AT, McCarthy MI, Ardlie KG, Hirschhorn JN, Daly MJ, Frayling TM, Groop L, Altshuler D. Evaluation of common variants in the six known maturity-onset diabetes of the young (MODY) genes for association with type 2 diabetes. Diabetes 2007, 56:685-693. 10.2337/db06-0202, 17327436.
65. Thorleifsson G, Walters GB, Gudbjartsson DF, et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nature Genetics 2009, 41:18-24. 10.1038/ng.274, 19079260.
66. Willer CJ, Speliotes EK, Loos RJ, et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nature Genetics 2009, 41(1):25-34. 10.1038/ng.287, 2695662, 19079261.
67. Scuteri A, Sanna S, Chen WM, Uda M, Albai G, Strait J, Najjar S, Nagaraja R, Orrú M, Usala G, Dei M, Lai S, Maschio A, Busonero F, Mulas A, Ehret GB, Fink AA, Weder AB, Cooper RS, Galan P, Chakravarti A, Schlessinger D, Cao A, Lakatta E, Abecasis GR. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet 2007, 3:e115. 10.1371/journal.pgen.0030115, 1934391,1934391, 17658951.
68. Herbert A, Gerry NP, McQueen MB, Heid IM, Pfeufer A, Illig T, Wichmann HE, Meitinger T, Hunter D, Hu FB, Colditz G, Hinney A, Hebebrand J, Koberwitz K, Zhu X, Cooper R, Ardlie K, Lyon H, Hirschhorn JN, Laird NM, Lenburg ME, Lange C, Christman MF. A common genetic variant is associated with adult and childhood obesity. Science 2006, 312:279-283. 10.1126/science.1124779, 16614226.
69. Liu YJ, Liu XG, Wang L, Dina C, Yan H, Liu JF, Levy S, Papasian CJ, Drees BM, Hamilton JJ, Meyre D, Delplanque J, Pei YF, Zhang L, Recker RR, Froguel P, Deng HW. Genome-wide association scans identified CTNNBL1 as a novel gene for obesity. Human Molecular Genetics 2008, 17(12):1903-1813.
70. Blakemore AI, Meyre D, Delplanque J, Vatin V, Lecoeur C, Marre M, Tichet J, Balkau B, Froguel P, Walley AJ. A rare variant in the visfatin gene (NAMPT/PBEF1) is associated with protection from obesity. Obesity 2009, 17(8):1549-1553. 10.1038/oby.2009.75, 19300429.
71. Yanagiya T, Tanabe A, Iida A, et al. Association of single-nucleotide polymorphisms in MTMR9 gene with obesity. Hum Mol Genet 2007, 16(24):3017-3026. 10.1093/hmg/ddm260, 17855449.
72. Meyre D, Delplanque J, Chèvre JC, et al. Genome-wide association study for early onset and morbid adult obesity identifies three new risk loci in European populations. Nature Genetics 2009, 41(2):157-159. 10.1038/ng.301, 19151714.
73. Dina C, Meyre D, Gallina S, Durand E, Körner A, Jacobson P, Carlsson LM, Kiess W, Vatin V, Lecoeur C, Delplanque J, Vaillant E, Pattou F, Ruiz J, Weill J, Levy-Marchal C, Horber F, Potoczna N, Hercberg S, Le Stunff C, Bougnères P, Kovacs P, Marre M, Balkau B, Cauchi S, Chèvre JC, Froguel P. Variation in FTO contributes to childhood obesity and severe adult obesity. Nature Genetics 2007, 39:724-726. 10.1038/ng2048, 17496892.
74. Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007, 316:889-894. 10.1126/science.1141634, 2646098, 17434869.
75. Loos RJ, Lindgren CM, Li S, et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nature Genetics 2008, 40(6):768-775. 10.1038/ng.140, 2669167, 18454148.
76. Chambers JC, Elliott P, Zabaneh D, Zhang W, Li Y, Froguel P, Balding D, Scott J, Kooner JS. Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nature Genetics 2008, 40(6):716-718. 10.1038/ng.156, 18454146.
77. Freeman JV, Cole TJ, Chinn S, Jones PR, White EM, Preece MA. Cross-sectional stature and weight reference curves for the UK, 1990. Archives of Disease in Childhood 1995, 73:17-24. 10.1136/adc.73.1.17, 1511167, 7639543.
78. Cole TJ, Freeman JV, Preece MA. Body Mass Index reference curves for the UK, 1990. Archives of Disease in Childhood 1995, 73:25-29. 10.1136/adc.73.1.25, 1511150, 7639544.